rs119450944
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000026.4(ADSL):c.736A>G(p.Lys246Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000026.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADSL | ENST00000623063.3 | c.736A>G | p.Lys246Glu | missense_variant | Exon 7 of 13 | 1 | NM_000026.4 | ENSP00000485525.1 | ||
ENSG00000284431 | ENST00000639722.1 | n.*432A>G | non_coding_transcript_exon_variant | Exon 6 of 31 | 5 | ENSP00000492828.1 | ||||
ENSG00000284431 | ENST00000639722.1 | n.*432A>G | 3_prime_UTR_variant | Exon 6 of 31 | 5 | ENSP00000492828.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251478Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135910
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461686Hom.: 0 Cov.: 30 AF XY: 0.0000495 AC XY: 36AN XY: 727154
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
Adenylosuccinate lyase deficiency Pathogenic:3
- -
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 246 of the ADSL protein (p.Lys246Glu). This variant is present in population databases (rs119450944, gnomAD 0.006%). This missense change has been observed in individual(s) with adenylosuccinate lyase deficiency (PMID: 1405483, 10090474, 27504266). ClinVar contains an entry for this variant (Variation ID: 2466). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ADSL protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ADSL function (PMID: 19405474). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect as this variant reduces ADSL enzyme activity (De Zoysa Ariyananda et al., 2009); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 1405483, 27504266, 21210713, 10888601, 23055421, 10090474, 19405474, 31440721) -
ADSL-related disorder Pathogenic:1
The ADSL c.736A>G variant is predicted to result in the amino acid substitution p.Lys246Glu. This variant was reported in the compound heterozygous state in three patients with adenylosuccinate lyase deficiency (Marie. 1999. PubMed ID: 10090474; Donti. 2016. PubMed ID: 27504266). Functional in vitro assays demonstrated this variant impairs enzyme kinetics and the ability to properly form a tetramer (Ariyananda. 2009. PubMed ID: 19405474). This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at